Researcher.Life Logo

Endokrynologia Polska : Impact Factor & More

eISSN: 2299-8306pISSN: 0423-104X
JournalOpen Access

Key Metrics

CiteScore
2.5
Impact Factor
< 5
SJR
Q3Medicine (all)
SNIP
0.62
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Endokrynologia Polska

Endokrynologia Polska Journal Specifications

Overview
Publisher VIA MEDICA
Language English,Polish
Frequency Bi-monthly
Article Processing ChargesEUR 500
Publication Time20
Editorial Review ProcessDouble anonymous peer review
General Details
LanguageEnglish,Polish
Society/Institute/SponsorPolish Society of Endocrinology
FrequencyBi-monthly
Publication Start Year1949
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 20
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessDouble anonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
License typeCC BY-NC-ND
OA statementVisit website
View less

Planning to publish in Endokrynologia Polska ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Endokrynologia Polska

MiR-4260 serves as a prognostic biomarker and suppresses thyroid cancer progression.
  • 13 Apr 2026
  • Endokrynologia Polska
When lymphadenopathy is not what it seems - coexistence of mantle cell lymphoma and pancreatic neuroendocrine tumor.
  • 10 Apr 2026
  • Endokrynologia Polska
Evaluation of incretin levels in patients with prolactinoma.
  • 9 Apr 2026
  • Endokrynologia Polska
Prognostic value of lncRNA HCG4 in thyroid cancer and its regulatory effect on tumor progression.
  • 9 Apr 2026
  • Endokrynologia Polska
Body mass index as a predictor of metabolic dysfunction‑associated steatotic liver disease - insights from the Polish Gallstone Surgery Registry.
  • 1 Jan 2026
  • Endokrynologia Polska
A comprehensive analysis of the impact of low AMH on ART outcomes in young patients.
  • 1 Jan 2026
  • Endokrynologia Polska
MiR-4260 serves as a prognostic biomarker and suppresses thyroid cancer progression.
  • 13 Apr 2026
  • Endokrynologia Polska
When lymphadenopathy is not what it seems - coexistence of mantle cell lymphoma and pancreatic neuroendocrine tumor.
  • 10 Apr 2026
  • Endokrynologia Polska
Evaluation of incretin levels in patients with prolactinoma.
  • 9 Apr 2026
  • Endokrynologia Polska
Prognostic value of lncRNA HCG4 in thyroid cancer and its regulatory effect on tumor progression.
  • 9 Apr 2026
  • Endokrynologia Polska
Body mass index as a predictor of metabolic dysfunction‑associated steatotic liver disease - insights from the Polish Gallstone Surgery Registry.
  • 1 Jan 2026
  • Endokrynologia Polska
A comprehensive analysis of the impact of low AMH on ART outcomes in young patients.
  • 1 Jan 2026
  • Endokrynologia Polska

FAQs on Endokrynologia Polska